Danaher is at ASGCT 2024

You’re invited to visit us in Baltimore

  • Workflow AutomationDate and Time
    May 7th - 11th

  • Workflow AutomationLocation
    Baltimore Convention Center
    Booth 1015, 1017, 1019 and 1114

cell-line

 

 

Visit the Life Sciences companies of Danaher Corporation at ASGCT 2024

Beckman Coulter Life Sciences

Beckman Coulter Life Sciences

For more than 80 years, Beckman Coulter has been a trusted partner for laboratory professionals, helping to advance scientific research and patient care.

SCIEX

SCIEX

SCIEX is the market leader in providing Mass Spectrometry and Capillary Electrophoresis solutions to address needs and challenges faced during therapeutic development. Our unique technologies enable scientists to achieve comprehensive characterization and sensitive quantification of various modalities, including protein therapeutics, cell & gene therapies, etc., in simple and complex biological matrices.

Molecular Devices

Molecular Devices

From our scientists and engineers to our service and support teams, we're passionate about equipping researchers with next-generation technology that advances scientific discovery. Our customers are at the heart of all we do, inspiring innovative solutions that unravel the complexity of biological systems and support the development of new therapeutics, to improve the quality of human life worldwide. We are Molecular Devices. Helping scientists harness the full potential of biology since 1983.

Rule line
Leica Microsystems

Leica Microsystems

Leica Microsystems develops leading-edge microscopes and scientific instruments to power technological advances and touch lives in meaningful ways.

IDBS

IDBS

IDBS provides purpose-built software solutions to address the data management challenges prominent across the BioPharma lifecycle and supply chain.

Phenomenex

Phenomenex

Phenomenex is a leading company in manufacturing reliable and high-quality column chemistry and solid phase extraction consumables to serve as control strategies for robust traditional and emerging therapeutic analytical methods.

 

 

Rule line
Aldevron

Aldevron

Aldevron provides critical nucleic acids and proteins used to make gene and cell therapies, gene editing technologies, DNA and RNA vaccines. 

Cytiva Pall

Cytiva + Pall

Cytiva and Pall Life Sciences have come together to deliver the breadth, depth, and scale researchers and biopharma need to advance future therapeutics—from discovery to delivery.

IDT

Integrated DNA Technologies (IDT)

For more than 35 years, Integrated DNA Technologies, Inc. (IDT) has been empowering genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, with the most advanced synthesis, modification, purification, and quality control capabilities available. Since its founding in 1987, IDT has progressed from a leading oligo manufacturer to a genomics solutions provider supporting key application areas such as NGS, CRISPR genome editing, synthetic biology, digital PCR, and RNAi.

Rule line
abcam

abcam

​​We believe the scientific community goes further, faster when we go there together. That’s why we partner with life scientists around the world to create innovative research solutions for cancer, neurological disorders, infectious diseases and more.

 

 

Rule line

Sign up for our newsletter

Stay up-to-date on the latest news and offerings from the Life Science Companies of Danaher

Rule line

Register now

Personalized Medicine

Personalized medicine aims to customize highly effective treatments to suit the specific needs of individual patients while reducing negative side effects. Achieving this requires robust solutions like advanced genome editing and automated process equipment. The Life Sciences operating companies of Danaher provide various innovative solutions and services to support your personalized medicine programs. Contact us today to learn more.

 

 

 

Analytics

Analytical laboratories play a crucial role in developing personalized medicines, as they verify critical quality attributes, aid in understanding mechanisms of action and ensure safety, among other things. The operating companies of Danaher Life Sciences offer a wide range of analytical solutions specifically designed for this purpose. From sample preparation to data analysis, these solutions can help simplify the process, save valuable sample volume, and deliver the precision and capabilities your lab requires. Our approach to shortening the time to market is to keep the process simple yet deliver the results your personalized medicine programs require.

 

 

 

Agenda and Abstracts

Tuesday, May 7, 2024

TimeBrandDescriptionRoom / LocationPresenter
4:15 PM – 4:30 PM ESTSCIEXMultiple quality attribute analysis of the mRNA and mRNA-lipid nanoparticle (mRNA-LNP) by capillary electrophoresis (CE)Exhibit Hall Theater - Tool and Technology Forum 4Tingting Li, Manager, Cell & Gene Therapy Applications, SCIEX

 

Wednesday, May 8, 2024

TimeBrandDescriptionRoom / LocationPresenter
12:00 PM ESTPhenomenex

AAV Vectors - Product Development Manufacturing and Approval Considerations

Size Exclusion Chromatography (SEC) is widely accepted to separate adeno-associated virus (AAV) monomer from its aggregates but analysis with current SEC columns require high volume sample consumption and lack robustness. Herein, Biozen™ dSEC-7, a chromatographic (SEC) column, is described and tested for various AAV serotype aggregates. Its 700 Å pore size, inert particle chemistry, and applicable particle size(s) are found to enable highly reproducible baseline separation and recoveries of the AAV monomer and its aggregates, even amongst batches of columns, within 10 minutes. The percentage relative standard deviations of the peak area, retention time, and % monomer were all < 1 % with as little as 0.5 µL of sample.  This performance enables faster and more accurate determination of AAV aggregates, a critical quality attribute (CQA) in drug substances and drug products, without compromising data quality.

 

Abstract Number: 540

Exhibit HallTran Pham
12:00 PM ESTIDT

Comparing the performance of different double-stranded DNA donor templates in CRISPR-Cas9 genome editing applications

 

Abstract Number: 734

Exhibit HallVaughn Thada

Friday, May 10, 2024

TImeBrandDescriptionRoom / LocationPresenter
12:00 PM ESTIDT

Nomination of Genome Wide CRISPR-Cas9 Cleavage Activity Using rhAmp Technology


Abstract Number: 1691

Exhibit HallRolf Turk
5:30 PM  ESTIDT

End-to-end Tools and Services for Interrogation of CRISPR-Cas Associated Genotoxicity

Learn about IDT's methods to identify and verify off-target editing events, gRNA synthesis errors, cross-contamination, or other unintended gRNA activity to prevent unexpected genotoxic effects for the gene editing therapeutic community.


Abstract Number: 1684

Exhibit HallEllen Schmaljohn